"10.1371_journal.pone.0133891","plos one","2015-07-27T00:00:00Z","Dimitra Koukou; Panagiota Chatzichristou; Georgios Trimis; Tania Siahanidou; Anna-Venetia Skiathitou; Emmanouil I Koutouzis; George A Syrogiannopoulos; Athanasia Lourida; Athanasios G Michos; Vassiliki P Syriopoulou","First Department of Pediatrics, Athens University, “Aghia Sophia” Children’s Hospital, Athens, Greece; Vaccine Unit, VIANEX/Sanofi Pasteur MSD, Athens, Greece; Department of Microbiology, “Aghia Sophia” Children’s Hospital, Athens, Greece; Department of Pediatrics, University of Thessaly, General University Hospital of Larissa, Larissa, Greece","Conceived and designed the experiments: DK GT VS PC. Performed the experiments: DK PC EIK. Analyzed the data: DK AM EIK. Contributed reagents/materials/analysis tools: TS AVS AL. Wrote the paper: DK PC GT GAS VS.","GlaxoSmithKline Biologicals and Sanofi Pasteur MSD and VIANEX provided funding towards this study. Georgios Trimis has to declare that he is Consultant in the pharmaceutical company VIANEX Athens-Greece, representative of Sanofi Pasteur MSD Lyon-France in Greece, which has the marketing authorization of RotaTeq (rotavirus vaccine) in Greece. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","07","Dimitra Koukou","DK",10,TRUE,4,3,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
